US Stock MarketDetailed Quotes

PRTA Prothena

Watchlist
  • 16.140
  • +0.260+1.64%
Trading Nov 29 10:35 ET
868.47MMarket Cap-6560P/E (TTM)

About Prothena Company

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Company Profile

SymbolPRTA
Company NameProthena
Listing DateDec 18, 2012
Founded2012
CEODr. Gene G. Kinney, PhD
MarketNASDAQ
Employees173
Fiscal Year Ends12-31
Address77 Sir John Rogersons Quay,Grand Canal Docklands,Block C
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-236-2500
Websitehttp://www.prothena.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Gene G. Kinney, PhD
  • Director, President and Chief Executive Officer
  • 7.04M
  • Michael J. Malecek
  • Chief Legal Officer and Company Secretary
  • --
  • Tran B. Nguyen
  • Chief Strategy Officer and Chief Financial Officer
  • 2.70M
  • Carol D. Karp
  • Chief Regulatory Officer
  • 2.57M
  • Chad J. Swanson
  • Chief Development Officer
  • --
  • Karin L. Walker
  • Chief Accounting Officer
  • --
  • Brandon S. Smith
  • Chief Operating Officer
  • 2.63M
  • Wagner M. Zago
  • Chief Scientific Officer
  • --
  • Dr. Radhika Tripuraneni, M.D.,M.P.H.
  • Chief Development Officer
  • --
  • Dr. Lars G. Ekman, M.D.,PhD
  • Chairman Emeritus and Director
  • 923.48K
  • Daniel G. Welch
  • Chairman of the Board
  • --
  • Dr. William H. Dunn, Jr
  • Director
  • 1.70M
  • Dr. Dennis J. Selkoe, M.D.
  • Independent Director
  • 901.73K
  • Paula K. Cobb
  • Independent Director
  • 908.48K
  • Oleg Nodelman
  • Independent Director
  • --
  • Shane M. Cooke
  • Independent Director
  • 917.26K
  • Helen S. Kim
  • Independent Director
  • 896.63K
  • Richard T. Collier
  • Independent Director
  • 912.48K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data